I am Group CFO at Rayner, a global ophthalmology business specialising in cataract surgical systems and products and notably in intraocular lenses and related technologies. Rayner has been backed by CVC Capital Partners since June 2021, and in May 2026 Groupe Bruxelles Lambert (GBL) invested alongside CVC. I joined the business as Group CFO in April 2023.
Prior to Rayner, I spent over a decade as CFO at HRA Pharma, a specialist pharmaceutical company focused on women’s health and rare diseases. I joined the business in 2011 when The Riverside Company was a minority investor alongside the founding families. I worked on developing the finance infrastructure and scaling the business to more than double revenue in four years. I negotiated the buyout by Astorg and Goldman Sachs Merchant Banking Division on behalf of the management and families in 2016, and we then executed a substantial value creation plan. This included delivering a buy-and-build strategy, with acquisitions such as Compeed and expansion into the US, which became the Group’s largest market. We also managed increasingly complex leveraged and syndicated debt structures, including interaction with rating agencies. Together with the Group CEO, we led the sale of the business to Perrigo, at an enterprise value of €1.8bn, with the transaction completing in May 2022.
Earlier in my career, I was CFO of Kewego, a venture-backed digital media business where I built and led the international finance organisation and supported the successful sale to KIT Digital in January 2011, later rebranded as Piksel.
I support PepTalks Members with:
- Delivering value creation through M&A and buy-and-build strategies
- Scaling and professionalising finance functions in PE-backed businesses
- Navigating private equity ownership, debt structures, and exit processes
